Interestingly, FOXO3A inhibits cyclin D1 expression in colorectal cancer as well as breast cancer [43,44] whereas GSK3 phosphorylates cyclin D1 on Thr286, leading to ubiquitination and proteasomal degradation of cyclin D1 [45,46]. Here, CCND1 is linked to breast cancer.